R. Lutter (Amsterdam, The Netherlands), F. Pavicic (Zagreb, Croatia)
Regulation of brain-derived neurotrophic factor (BDNF) during acute lower respiratory tract infections of the adult
M. Lommatzsch, A. Niewerth, J. Klotz, C. Zingler, O. Schulte-Herbruggen, J. C. Virchow (Rostock, Berlin, Germany)
|  |
Cigarette smoke causes increased susceptibility to respiratory pathogens: role for innate immunity toll-like receptor (TLR4) inactivation
S. Bozinovski, R. Vlahos, G. P. Anderson (Parkville, Australia)
| |
Transcript profiling of alveolar macrophages reveals a unique molecular finger print compared to CD14++ and CD14+CD16+ monocytes in blood
M. Frankenberger, T. Hofer, J. Mages, R. Hoffmann, F. Stanzel, L. Ziegler-Heitbrock (München-Gauting, Munich, Germany; Leicester, United Kingdom)
| |
Contribution of myeloperoxidase to inflammatory processes in lung epithelial cells
A. Haegens, J. H. J. Vernooy, E. F. M. Wouters (Maastricht, Netherlands)
| |
A possible role of intracellular calcium in the development of anti-cancer therapy -resistance in lung cancer cells
A. Kemp da Silva, J. Kellner, H. Oelmez, F. Gamarra, A. Bergner, R. M. Huber (Munich, Germany)
| |
Endogenous IL-13Rα2 does not induce TGFβ1 release from bronchial fibroblasts
A. L. Andrews, C. B. Boxall, L. M. Hamilton, J. W. Holloway, S. T. Holgate, D. E. Davies (Southampton, United Kingdom)
| |
Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
C. Waizenegger, C. Neurohr, H. Villena-Hermoza, H. H. Leuchte, R. Baumgartner, R. Hatz, J. Behr (Munich, Germany)
| |
Morphological and functional changes induced by bradykinin in human airway fibroblasts
F. Sabatini, C. Usai, S. Carnevali, L. Petecchia, C. Vanni, A. Eva, L. M. Fabbri, G. A. Rossi, F. L. M. Ricciardolo (Genoa, Modena, Italy)
| |
Effects of cigarette smoke extract on in vitro differentiated bronchial epithelial cells from subjects with and without COPD
G. Skibinski, S. Sarlang, J. S. Elborn, M. Ennis (Belfast, United Kingdom)
| |
Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK
J. M. Hughes, H. Alkhouri, E. Chen, Y. Alrashdan, Q. Ge, C. L. Armour, S. Henness, A. J. Ammit (Sydney, Australia)
| |
Epigallocatechin-gallate, the main polyphenolic constituent of green tea, inhibits the migration of an invasive epithelial bronchial cell line
S. Hazgui, J. M. Zahm, N. Bonnet (Reims, France)
| |
Dexamethasone inhibits surfactant degradation during bleomycin-induced lung injury in rats
O. A. Golovach, A. D. Tahanovich, A. S. Smirnou, L. M. Labanava (Minsk, Belarus)
| |
Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan in vitro
W. Zhuo, Z. Chen, Y. Wang (Chongqing, China)
| |
Increased numbers of inflammatory cells but decreased activation of NFκB pathway in small airways of endurance-trained mice
L. Chimenti, G. Morici, A. Paternò, L. Siena, A. Bonanno, A. Licciardi, M. Veca, M. Di Bella, R. Gagliardo, V. Bellia, M. R. Bonsignore (Palermo, Italy)
| |
Morphometric study of telomerase activity in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays
A. Tzouvelekis, E. Tsiambas, A. Karameris, A. Koutsopoulos, R. Triggidou, M. Froudarakis, P. Steiropoulos, M. Doris, S. Anevlavis, D. Bouros (Alexandroupolis, Athens, Heraklion, Greece)
| |
Regulation of human airway smooth muscle migration and matrix production by PPAR-ligands
P. Nair, K. Radford, J. Stephen, H. Patel, P. Bilan, G. Cox, J. Capone (Hamilton, Canada)
| |
Expression of cysteinyl leukotriene 1 receptor in peripheral blood stem cell-derived human basophils
Y. Tanimoto, N. Suzaki, M. Sakugawa, Y. Ogata, Y. Inoue, N. Hamada, K. Takahashi, M. Tanimoto (Okayama, Hayashima-cho, Japan)
| |
The inhibitory effect of IFN-gamma on collagen production is partially mediated by SOCS-1
H. Shoda, A. Yokoyama, N. Hattori, N. Kohno, T. Naka (Hiroshima, Osaka, Japan)
| |
Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases
D. Hartl, I. Bittmann, D. Reinhardt, S. Krauss-Etschmann, M. Griese, D. Roos (Munich, Germany; Amsterdam, Netherlands)
| |
Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
E. M. Drost, C. A. Poland, K. Donaldson, W. MacNee (Edinburgh, United Kingdom)
| |